Raphael Bitya, Gabet Yankel
J Basic Clin Physiol Pharmacol. 2016 May 1;27(3):237-45. doi: 10.1515/jbcpp-2015-0073.
Recently, there has been a rapidly growing interest in the role of cannabinoids in the regulation of skeletal remodeling and bone mass, addressed in basic, translational and clinical research. Since the first publications in 2005, there are more than 1000 publications addressing the skeletal endocannabinoid system. This review focuses on the roles of the endocannabinoid system in skeletal biology via the cannabinoid receptors CB1, CB2 and others. Endocannabinoids play important roles in bone formation, bone resorption and skeletal growth, and are sometimes age, gender, species and strain dependent. Controversies in the literature and potential therapeutic approaches targeting the endocannabinoid system in skeletal disorders are also discussed.
近年来,基础研究、转化研究和临床研究均表明,大麻素在骨骼重塑和骨量调节中的作用正迅速成为研究热点。自2005年首次发表相关论文以来,已有1000多篇关于骨骼内源性大麻素系统的出版物。本综述重点关注内源性大麻素系统通过大麻素受体CB1、CB2及其他受体在骨骼生物学中的作用。内源性大麻素在骨形成、骨吸收和骨骼生长中发挥重要作用,且有时具有年龄、性别、物种和品系依赖性。本文还讨论了文献中的争议以及针对骨骼疾病内源性大麻素系统的潜在治疗方法。